Histacon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Histacon

Histacon is defined as a fixed-dose combination (FDC) medicinal product, containing multiple synthetic active ingredients to address the range of discomforts associated with the common cold or flu. It is an Over-the-Counter (OTC) medicine, primarily taken by the oral route of administration in forms such as tablets, capsules, or oral liquid suspensions.

Property Description
Active ingredient Paracetamol, Caffeine, Chlorpheniramine Maleate, Phenylephrine Hydrochloride
Form Tablets, capsules, oral liquid suspension
Pharmacological Class Analgesic, Antipyretic, Antihistamine, Decongestant
Common Use Symptomatic relief of cold and flu symptoms
Origin Synthetic

The Active Composition and Pharmaceutical Identity

The core of Histacon lies in its quartet of active ingredients [INN]: Paracetamol (Acetaminophen), a standard agent for fever and pain; Chlorpheniramine Maleate, a first-generation antihistamine; Phenylephrine Hydrochloride, a nasal decongestant; and Caffeine, a mild psychostimulant. This blend gives the product a broad identity, allowing it to be classified as an upper respiratory combination product. This type of combination is clinically recognized for its utility in targeting the overlapping symptoms of viral upper respiratory tract infections.

A review of combination products highlights that the inclusion of Paracetamol is fundamental for its analgesic and antipyretic function, helping to ease widespread body aches and elevated temperature. Furthermore, the combination's decongestant component, Phenylephrine, works to constrict nasal blood vessels, a mechanism which has been demonstrably effective in pharmacological studies for easing nasal congestion.


General Purpose: Integrated Symptom Management

The general therapeutic purpose of Histacon is to provide comprehensive symptomatic relief through the integrated action of its components. This FDC formulation is often positioned for a patient experiencing concurrent headache, mild fever, and a blocked nose due to a common cold. By combining agents that manage systemic issues (pain and fever) with those that control local symptoms (sneezing, runny nose, and nasal obstruction), the preparation's primary utility is to modulate the chief physical manifestations of cold and flu. This integrated design supports patient comfort during the self-limiting course of a respiratory infection, providing multisymptom relief in a single product.

Regulatory References

  1. Phenylephrine HCl Drug Facts (DailyMed/NIH)
  2. DailyMed Basics (Dosage Forms)
  3. Chlorpheniramine Maleate Drug Label (DailyMed/NIH)
  4. Caffeine Drug Label (DailyMed/NIH)

What side effects are possible with Histacon?

Possible Side Effects and Safety Information

The officially documented safety profile of Histacon, a combination product, details adverse reactions classified by frequency and affected body systems, as established in regulatory labeling. The most frequently observed effects relate to the central nervous system (CNS) and anticholinergic activity.

Frequency-Classified Adverse Reactions

Frequency (Regulatory Standard) Example Adverse Reactions
Very Common Sedation, Somnolence (Drowsiness), Dry mouth
Common Headache, Dizziness, Insomnia, Nervousness, Nausea
Rare / Very Rare Blood Dyscrasias, Severe Hepatotoxicity, Severe Skin Reactions (SJS, TEN)

Serious adverse reactions, though rare, are critical elements of the safety profile. These include severe hepatotoxicity or liver failure, primarily associated with the Paracetamol component, and severe blistering skin reactions (e.g., SJS, TEN). Due to the Phenylephrine content, risks of severe hypertensive episodes are documented, particularly in susceptible individuals. The most commonly affected system-organ classes are Nervous System, Cardiac, Gastrointestinal, and Hepatobiliary Disorders.

Population-Specific Safety Considerations

The official labeling outlines specific restrictions, including contraindication in patients with severe active liver disease, severe hypertension, or severe coronary artery disease. Use in older adults is constrained due to increased sensitivity to the CNS and anticholinergic effects of the components. A strict safety limitation requires patients not to take anything else containing paracetamol to prevent the risk of severe, delayed liver injury. Sedation is often more prominent at the start of treatment, consistent with time-related patterns described in regulatory documents.

Overdose and Emergency Response

Documented Overdose Manifestations

Overdose with this fixed-dose combination product may initially present with non-specific symptoms such as nausea, vomiting, lethargy, pallor, and diaphoresis. Severe manifestations are primarily driven by the components' documented toxicities. The Paracetamol component poses a risk of delayed, potentially fatal hepatic necrosis and hepatic failure. Furthermore, the antihistamine and sympathomimetic components can lead to acute Central Nervous System (CNS) effects, ranging from stupor and apnoea to convulsions and paradoxical excitation, alongside risks of severe cardiac arrhythmias and hypertensive crisis.

Mandated Emergency Actions

Regulatory guidance mandates that a person seek immediate medical attention for any suspected overdose, even if initial symptoms are absent. This is a critical requirement due to the potential for delayed, severe liver injury stemming from the Paracetamol component. Contacting a Poison Control Center right away is required. Individuals with chronic alcoholism or pre-existing liver disease, along with children and the elderly, are noted in regulatory documents to be at increased risk of severe toxicity.

Official Management Statements

Official management protocols address the combined toxicities. The antidote N-acetylcysteine (NAC) is specifically indicated to prevent or reduce the hepatic injury caused by the Paracetamol component. Symptomatic and supportive treatment is required to manage CNS instability and cardiovascular events. Procedural instructions include monitoring of hepatic function (e.g., ALT, AST, INR) and plasma Paracetamol levels.

Therapeutic Uses of Histacon

Histacon: Main Uses and Benefits

Histacon is prescribed to provide temporary relief of symptoms associated with allergic rhinitis (hay fever) and the common cold or other upper respiratory conditions. Its therapeutic function focuses on addressing symptoms such as a runny nose, sneezing, watery eyes, itchy eyes, and nasal congestion.


Main Uses

The primary therapeutic uses of Histacon include managing the symptoms of:

  • Seasonal and perennial allergic rhinitis
  • Acute coryza (the common cold)
  • Sinusitis and bronchitis (to relieve associated respiratory symptoms)

Therapeutic Benefits

Using Histacon offers the benefit of symptom management for conditions mediated by histamine release. It helps to relieve congestion in the nose and ears and reduces the severity of other bothersome allergic symptoms. The goal of treatment is to enhance comfort and support daily functioning by temporarily reducing these symptoms. It is important to note that this medication manages symptoms and does not cure the underlying condition.


Quick Facts

  • Treats: Allergic rhinitis, common cold symptoms.
  • Relieves: Runny nose, sneezing, watery eyes, itchy eyes, nasal congestion.
  • Benefit: Temporary symptom management and relief of discomfort.

Eligibility and Restrictions for Use

Histacon's eligibility is strictly defined by regulatory guidelines based on its four active components. Official documentation identifies populations that are contraindicated, restricted, or require caution.

Populations Contraindicated

Use of this medicine is strictly contraindicated for several high-risk groups. This includes individuals with known hypersensitivity to any active ingredient, severe hepatic impairment or severe renal impairment, severe hypertension, or severe cardiovascular disease. It is prohibited for patients currently taking or having recently discontinued Monoamine Oxidase Inhibitors (MAOIs), and those diagnosed with closed-angle glaucoma or phaeochromocytoma.

Age and Conditional Restrictions

Regulatory agencies do not recommend Histacon for children under 12 years of age. Use during pregnancy and breastfeeding is also not recommended due to potential risks noted in official documentation. The medicine requires use with caution in populations with conditions such as diabetes mellitus, hyperthyroidism, prostatic hypertrophy, or mild-to-moderate liver or kidney dysfunction. Furthermore, patients must not use Histacon concurrently with other products containing Paracetamol or other sympathomimetic decongestants.

What should I know about interactions with other medicines?

Histacon Interactions with other medicines and products

The official interaction profile for Histacon, a combination medicine, is structured around documented pharmacokinetic and pharmacodynamic risks associated with its components.

Interaction Scope

Category Regulatory Summary
Prohibited Combinations Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the risk of severe blood pressure elevation (hypertensive crisis) and requires a 14-day separation period following the discontinuation of the MAOI.
Pharmacodynamic Interactions Co-administration with Alcohol or CNS Depressants may result in additive CNS depression. Tricyclic Antidepressants and other noradrenergic agents may potentiate the pressor effect of Phenylephrine.
Exposure Restrictions Restriction on co-administration with any other product containing Paracetamol is mandated to avoid exceeding the maximum daily dose and the risk of dose-dependent hepatotoxicity.
Metabolic Considerations Chronic alcohol use is documented to increase the risk of Paracetamol-induced liver injury. The Chlorpheniramine component may inhibit the hepatic metabolism of specific medicines, such as Phenytoin, altering its exposure.

Interaction Classification

The profile includes Contraindicated Combinations (MAOIs) and Clinically Significant Interactions with multiple pharmacologic classes, reflecting a high-level severity classification defined in official regulatory documents.

Official Interaction Statements

  • Co-administration with MAOIs is prohibited and requires a minimum 14-day separation period.
  • The risk of additive CNS depression exists with co-administered alcohol or CNS depressants.
  • Caffeine-containing foods/beverages may lead to the augmentation of stimulant side effects.
  • A restriction on co-administration with other Paracetamol-containing products is enforced due to the risk of hepatotoxicity.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documents define this product's interaction structure through mandatory prohibitions, explicit timing-based rules, and documentation of additive pharmacodynamic effects such as CNS depression and increased pressor activity. The profile further details pharmacokinetic and toxicological constraints, including the documented risks of Paracetamol exposure when combined with alcohol or other Paracetamol-containing products.

Mechanism of Action

️ Central Control of Temperature and Nociception Signaling

This domain addresses the action of Paracetamol, which primarily acts within the Central Nervous System ( CNS) by inhibiting COX enzymes in the hypothalamus. This inhibition reduces the synthesis of Prostaglandin E2 ( PGE2), a chemical mediator that elevates the body's thermal set point. This mechanistic adjustment influences the CNS thermal set point and supports the modulation of nociceptive signaling.


Vascular Tone Regulation and Histamine Blockade

This composite domain involves two complementary mechanisms: Phenylephrine and Chlorpheniramine. Phenylephrine selectively activates alpha1-adrenergic receptors on nasal blood vessels, causing vasoconstriction and reducing mucosal blood volume. Simultaneously, Chlorpheniramine acts as an H1 receptor antagonist, blocking the effects of histamine and restricts H1-mediated increases in capillary permeability and glandular secretion.


CNS Inhibitory Pathway Counteraction

The final component, Caffeine, exerts its effect by acting as an antagonist at A1 and A2 A Adenosine receptors in the CNS. Adenosine is a naturally occurring inhibitory neurotransmitter; therefore, blocking its receptors promotes neuronal disinhibition. This mechanism serves as a functional counteraction to the central depressant properties associated with the H1 antagonism of Chlorpheniramine.

Dosage and Administration Information

Histacon is an oral, fixed-dose combination product with usage defined for short-term, intermittent relief. The administration protocol focuses on precise dosing and adherence to strict time intervals.

Dosing Scope Dosing Instruction
Route of Administration Oral (via tablet, caplet, or liquid suspension).
Adult Dosing Regimen Take 1 to 2 units every 4 to 6 hours as needed. Do not exceed 8 units in 24 hours.
Inter-Dose Interval A minimum of 4 hours must pass between doses.
Duration Constraint Use is limited to a short course; do not use continuously for more than 7 days.

Age-Group Administration Rules

  • Children 12 years and older: Follows the standard adult regimen.
  • Children under 12 years: Dosing is typically reduced or requires specific guidance, with the product not recommended for children under 4 years old.

Special Procedural Conditions

Tablets and caplets must be swallowed whole with water; they are not to be crushed, chewed, or dissolved. A crucial administration rule is to avoid taking any other medication that contains paracetamol/acetaminophen while using this product, as this is a constraint for the combination formula.


The instructions establish a structured, intermittent use protocol for Histacon, governing administration via the oral route with strict numerical limits on unit dose, inter-dose interval, and the maximum 24-hour quantity. This framework mandates precise adherence to these parameters and the short duration limit, defining the standardized approach to proper administration.

Recent Clinical Evidence

Histacon is an antihistamine that has been evaluated across various stages of clinical research, primarily focusing on its use in managing histamine-mediated conditions such as allergic rhinitis (hay fever) and urticaria (hives).

Research Overview

Clinical Trial Focus

The body of evidence, including randomized controlled trials (RCTs) and systematic reviews, focuses on key outcomes such as the reduction of allergic symptoms (e.g., sneezing, itching, runny nose, and wheal/pruritus scores).

Studies have investigated the drug's activity as a selective antagonist of the H1 histamine receptor. This research aims to understand how the drug works to prevent histamine from binding to H1 receptors, a central process in acute allergic response and inflammation.

Efficacy and Observed Outcomes

Clinical studies have explored whether Histacon is associated with symptom improvement in both seasonal and perennial allergic rhinitis. In these trials, a rapid onset of symptom change was reported, with observed effects often beginning within the first hour of administration. These studies also evaluated the drug's role in the management of chronic spontaneous urticaria (CSU), noting observed reductions in itch severity and the number of wheals.

Type of Study Primary Focus Key Observation
Phase III RCTs Allergic Rhinitis (AR) Symptom reduction versus placebo.
Meta-analyses Chronic Urticaria (CSU) Observed reduction in itch/wheal scores.

Safety and Tolerability

Histacon is generally classified as a newer (second or third) generation antihistamine. Clinical trials suggest it does not readily cross the blood-brain barrier, which is a key factor evaluated in safety studies. The most commonly reported adverse events in clinical trials were mild and transient, primarily including headache and dry mouth. Studies specifically investigated the incidence of central nervous system (CNS) effects, such as somnolence, comparing it against both placebo and older-generation antihistamines.

Frequently Asked Questions (FAQ)

Common questions about Histacon (FAQ)


Q: How long does the effect of Histacon last?

Official product information suggests that the duration of effect is generally between 4 to 6 hours, which aligns with the advised inter-dose interval defined in the administration protocol. This duration reflects the time it takes for the components, such as the pain reliever, to be processed by the body. The specific half-life (the time it takes for half of the drug to be eliminated) varies greatly among the multiple active ingredients.


Q: Does Histacon interact with common pain relievers?

Official regulatory warnings prohibit co-administration with any other product containing Paracetamol (Acetaminophen), as this could lead to a serious risk of dose-dependent liver injury. However, the combination formula is generally considered compatible with non-prescription pain relievers like non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.


Q: Why is Histacon sometimes called a 'non-sedating' medicine?

Official product information notes that Histacon contains Chlorpheniramine, a first-generation antihistamine known to cause sleepiness. However, the medicine also includes Caffeine, a central nervous system (CNS) stimulant. The Caffeine component is understood to provide a functional counteraction to the central depressant properties associated with the antihistamine component.


Q: What should I do if I feel dizzy after taking Histacon?

Dizziness is documented in official sources as a commonly reported side effect. Regulatory warnings describe that symptoms such as dizziness or confusion that become severe or persist, or are accompanied by a suspected allergic reaction, may require seeking immediate medical attention.


Q: Are there any major foods I need to avoid while on Histacon?

Regulatory documents note that co-administration with caffeine-containing foods or beverages may lead to the augmentation of stimulant side effects, as Histacon already contains the stimulant Caffeine. No other specific food groups are universally restricted according to official labeling.


Q: What if I take too much Histacon by mistake?

An overdose of this medicine is considered a medical emergency. Due to the Paracetamol content, taking too much can cause severe, irreversible liver damage (hepatotoxicity), which may be fatal. Official documents state that a suspected overdose requires immediate contact with a poison control center or emergency medical services, even in the absence of obvious symptoms.


Q: How is Histacon different from an antihistamine?

Histacon is defined as a fixed-dose combination product, which means it contains multiple active ingredients from different drug classes. While one of its components is the antihistamine Chlorpheniramine, the medicine also includes a pain reliever, a decongestant, and a stimulant to address multiple cold and flu symptoms simultaneously.


Q: Are there any warnings about using heavy machinery while taking Histacon?

Official regulatory warnings describe the potential for drowsiness, impaired concentration, or dizziness. Therefore, users should be aware of this potential when engaging in activities that require mental alertness, such as driving a vehicle or operating heavy machinery.


Q: What does the research say about Histacon's use in children under 6?

Official guidance states that this medicine is not recommended for children under 12 years of age, with some regulatory bodies specifically recommending against use in children under 6 years. This restriction is primarily based on a lack of established efficacy and documented safety concerns for cold and cough symptom relief in very young children.


Q: What is the latest research on the effectiveness of Histacon?

Official regulatory documents summarize the evidence from clinical trials and systematic reviews supporting Histacon's use for symptom management. Key areas of focus confirm its function as an H1 antagonist and its rapid onset of action, especially in reducing symptoms of allergic rhinitis (hay fever) and urticaria (hives).


Q: Is it possible for Histacon to cause anxiety?

The official side effect list includes commonly reported symptoms such as nervousness and insomnia, which are often linked to the stimulant component, Caffeine. Regulatory text also indicates that symptoms such as restlessness and agitation can occur, particularly with high doses of the formula's components.


Q: What happens if I miss a dose of Histacon?

Official instructions for a missed dose describe that it can be taken as soon as the omission is noticed. However, if the time approaches the next scheduled administration, the instructions indicate the missed dose is typically skipped entirely. The regulatory guidance consistently states that a double dose must not be taken to compensate for a missed one.


Q: Can Histacon be taken with food, or does it matter?

Official patient information states that this medicine can be taken with or without food. If gastrointestinal discomfort occurs, taking the medicine with food or milk is sometimes described as a way to ease the discomfort. Regulatory instructions specify that tablets or caplets must be swallowed whole with water.


Q: Does Histacon cause long-term side effects?

Histacon is licensed by regulatory bodies for short-term, intermittent relief, with use strictly limited to a maximum of 7 days. Regulatory documents do not contain efficacy or safety data for continuous, long-term use, reflecting the constraint on duration set by official labeling.


Q: Does taking Histacon make you more sensitive to sunlight?

The Chlorpheniramine component has been noted in official product information to potentially increase sensitivity to sunlight (photosensitivity). Regulatory documents mention that users may need to consider protective measures, such as wearing appropriate clothing or using sunscreen.


Q: Are there known interactions between Histacon and herbal supplements?

Official guidelines describe that combining this medicine with herbal products may carry an increased risk of additive side effects, especially if the herbal product also causes effects like drowsiness or dry mouth. Regulatory information recommends that users ensure the compatibility of all products with a healthcare professional.


Q: Does Histacon affect fertility?

Official regulatory documents do not contain sufficient data regarding the effects of Histacon on human fertility. However, animal studies conducted on the individual components of the combination formula have been reviewed and generally indicate no documented evidence that they impair fertility.


Q: Is Histacon an addictive medication?

This medicine is not classified as a controlled substance and is not generally associated with clinical addiction or substance dependence. While reports of misuse or dependence on the antihistamine component have been documented at very high doses, the product is primarily used for short-term symptomatic relief.


Q: Can I use Histacon for pet allergies?

The medicine is officially indicated for the symptomatic relief of upper respiratory allergies, including allergic rhinitis (hay fever). It is not limited to specific allergen sources (like pollen or dust) but is used to manage the resulting histamine-mediated symptoms.

How should Histacon be stored and disposed of?

Histacon must be stored according to regulatory labeling to maintain its stability and effectiveness.

Storage Conditions

Condition Requirement (Official Labeling)
Temperature Store below 30 C (86 F).
Protection Protect the product from light and excessive moisture.
Handling Do not freeze the medicine.
Container Keep in a well-closed container and do not use past the expiration date.

Safety and Disposal

Official labeling requires that the medicine be kept out of the sight and reach of children to prevent accidental exposure.

Disposal instructions mandate that unused or expired Histacon must not be thrown away via wastewater or household waste. Instead, individuals are instructed to ask a pharmacist for guidance on the proper disposal method to ensure environmental safety.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Histacon found in:

A-Z Index: